Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-04-19
2005-04-19
O'Sullivan, Peter (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C564S182000
Reexamination Certificate
active
06881755
ABSTRACT:
The compounds of formula 1,wherein R and R2are as defined in the disclosure, are useful in the prevention and treatment of tissue damage due to exacerbated recruitment of polymorphonuclear neutrophils (PMN leukocytes) at the inflammatory sites.
REFERENCES:
patent: 4082707 (1978-04-01), Orzalesi et al.
patent: 5006542 (1991-04-01), Hall et al.
patent: 5633287 (1997-05-01), Lee et al.
patent: 6117909 (2000-09-01), Krause
patent: 6166064 (2000-12-01), Dombroski et al.
patent: 0849256 (1998-06-01), None
patent: 53-111030 (1978-09-01), None
Kakeya et al., Tetrahedron Letters, vol. 32, No. 10, pp. 1343-1346 (1991).
Regit, Chemische Berichte, vol. 98, No. 4, pp. 1210-1024 (1965).
Belletire et al., Tetrahedron Letters, vol. 27, No. 2, pp. 131-134 (1986).
Allegretti Marcello
Bertini Riccardo
Bizzarri Cinzia
Caselli Gianfranco
Cesta Maria Candida
Dompe S.p.A.
O'Sullivan Peter
LandOfFree
N-(2-aryl-propionyl)-sulfonamides and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(2-aryl-propionyl)-sulfonamides and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(2-aryl-propionyl)-sulfonamides and pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3401249